To hear about similar clinical trials, please enter your email below
Trial Title:
A Multi-omics-based Metabolic Typing Study of Gastric Cancer
NCT ID:
NCT06134011
Condition:
Gastric Cancer
Multi-omics
Diagnosis
Conditions: Official terms:
Stomach Neoplasms
Study type:
Observational [Patient Registry]
Overall status:
Active, not recruiting
Study design:
Time perspective:
Other
Intervention:
Intervention type:
Other
Intervention name:
Without any intervention
Description:
There were no special interventions for the two groups.
Arm group label:
Cancer tissues
Arm group label:
Normal adjacent tissues
Summary:
In the study, the investigators obtained gastric cancer tissues from 480 gastric cancer
patients who had undergone surgery at the Zhejiang Cancer Hospital's biospecimen bank
between 2012-2019, and obtained relevant clinical information. The gastric cancer tissues
were subjected to transcriptomic, metabolomic and other multi-omics testing, and analyzed
for the metabolic changes of gastric cancer, and proposed to discover relevant
therapeutic targets.
Criteria for eligibility:
Study pop:
These cases have histologically or cytologically confirmed gastric cancer and there are
no other tumors
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- 18≤age≤80
- Histologically or cytologically confirmed gastric cancer
- Undergo surgery for radical or palliative gastric cancer (both open and
laparoscopic)
- Patients with survival follow-up information
Exclusion Criteria:
- Two or more kinds of malignant tumors at the same time
- Incomplete or missing case information
- Preoperative diagnosis of residual gastric cancer
Gender:
All
Minimum age:
18 Years
Maximum age:
80 Years
Locations:
Facility:
Name:
Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital)
Address:
City:
Hangzhou
Country:
China
Start date:
September 10, 2023
Completion date:
September 10, 2024
Lead sponsor:
Agency:
Zhejiang Cancer Hospital
Agency class:
Other
Source:
Zhejiang Cancer Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06134011
